Schizophrenie, schizotype und wahnhafte Störungen (F2)

Bäuml J, Pitschel-Walz G, Berger H, Gunia H (2010) Arbeitsbuch PsychoEdukation bei Schizophrenie (APES). Mit Manual zur Gruppenleitung. Schattauer, StuttgartGoogle Scholar

Bayer TA, Falkai P, Maier W (1999) Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the «two hit hypothesis”. J Psychiatr Res 33: 543–548PubMedCrossRefGoogle Scholar

Correll CU (2010) Understanding schizoaffective disorder: from psychobiology to psychosocial functioning. J Clin Psychiatry 71 (Suppl 2): 8–13PubMedCrossRefGoogle Scholar

Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) (2006) S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Bd 1: Behandlungsleitlinie Schizophrenie. Steinkopff, DarmstadtGoogle Scholar

Falkai P (2008) Diagnose, Ätiologie und Neuropathologie der Schizophrenie. In: Kircher T, Gauggel S (Hrsg) Neuropsychologie der Schizophrenie. Symptome, Kognition, Gehirn. Springer, Berlin Heidelberg, S 36–43CrossRefGoogle Scholar

Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636–645PubMedCrossRefGoogle Scholar

Habel U, Klein M, Shah NJ, Toni I, Zilles K, Falkai P, Schneider F (2004) Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry 161: 1806–1813PubMedCrossRefGoogle Scholar

Henquet C, Murray R, Linszen D, van Os J (2005) The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31: 608–612PubMedCrossRefGoogle Scholar

Hinsch R, Pfingsten U (2007) Gruppentraining sozialer Kompetenzen (GSK). Grundlagen, Durchführung, Anwendungsbeispiele. Beltz, WeinheimGoogle Scholar

Jørgensen P, Bennedsen B, Christensen J, Hyllested A (1996) Acute and transient psychotic disorder: comorbidity with personality disorder. Acta Psychiatr Scand 94: 460–464PubMedCrossRefGoogle Scholar

Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D (2010) Remission in schizophrenia: validity, frequency, predictors, and patient’s perspective 5 years later. Dialogues Clin Neurosci 12: 393–407PubMedGoogle Scholar

Leucht S, Heres S, Kissling W, Davis JM (2011) Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol 6: 1–16Google Scholar

Nelson HE (2010) Kognitiv-behaviorale Therapie bei Wahn und Halluzinationen. Ein Therapieleitfaden. Schattauer, StuttgartGoogle Scholar

Nordentoft M, Jeppesen P, Abel M, Kassow P, Petersen L, Thorup A, Krarup G, Hemmingsen R, Jørgensen P (2002) OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomized controlled trial. Br J Psychiatry Suppl 43: s98-s106PubMedCrossRefGoogle Scholar

Nuechterlein KH, Dawson ME (1984) A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 10: 300–312PubMedGoogle Scholar

Roder V, Brenner HD, Kienzle N (2008) Integriertes Psychologisches Therapieprogramm bei schizophren Erkrankten. IPT. Beltz, WeinheimGoogle Scholar

Schneider F, Habel U, Reske M, Kellermann T, Stöcker T, Shah NJ, Zilles K, Braus DF, Schmitt A, Schlösser R, Wagner M, Frommann I, Kircher T, Rapp A, Meisenzahl E, Ufer S, Ruhrmann S, Thienel R, Sauer H, Henn FA, Gaebel W (2007) Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophr Res 89: 198–210PubMedCrossRefGoogle Scholar

Schneider F, Gur RC, Koch K, Backes V, Amunts K, Shah NJ, Bilker W, Gur RE, Habel U (2006) Impairment in the specificity of emotion processing in schizophrenia. Am J Psychiatry 163: 442–447PubMedCrossRefGoogle Scholar

Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H (1992) Neurological soft signs in schizophrenia. Schizophr Res 6: 25–30CrossRefGoogle Scholar

Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47: 27–38PubMedGoogle Scholar

Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717–719PubMedCrossRefGoogle Scholar

Shepherd M, Watt D, Falloon I, Smeeton N (1989) The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Cambridge University Press, CambridgeGoogle Scholar

Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187–1192PubMedCrossRefGoogle Scholar

Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, van Erp TG, Thompson PM, Toga AW, Cannon TD, Pantelis C (2009) Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res 108: 85–92PubMedCrossRefGoogle Scholar

Vernaleken I (2008) Pharmakodynamik und klinisches Wirkprofil antipsychotischer Substanzen. Psychiatr Psychother up2date 2: 365–388CrossRefGoogle Scholar

Vieta E (2010) Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation. J Clin Psychiatry 71 (Suppl 2): 14–19PubMedCrossRefGoogle Scholar

Zubin J, Spring B (1977) Vulnerability – a new view of schizophrenia. J Abnorm Psychol 86: 103–126PubMedCrossRefGoogle Scholar